Search

Survivorship

D200

UNDERSTANDING BASAL CELL ADENOCARCINOMA OF THE HEAD AND NECK: A POPULATION-BASED STUDY

Salivary

Lena Sheorey, BS1, Neel R Sangal, BA1, Rohan Sawhney, BA1, Soly Baredes, MD, FACS2, Richard Chan Woo Park, MD, FACS1

1Department of Otolaryngology – Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA, 2Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, USA


D201

CARCINOMA EX PLEOMORPHIC ADENOMA: A HIGH-GRADE TUMOR WITH GOOD SURVIVAL

Salivary

Avigeet Gupta, BS, Sina Koochakzadeh, BS, David M Neskey, MD, MSCR, Shaun A Nguyen, MD, MA, Eric J Lentsch, MD

Medical University of South Carolina


D202

THE USE OF COMPRESSION DRESSING AFTER PAROTIDECTOMY IMPROVES THE RATE OF SIALOCELE/SALIVARY FISTULA FORMATION

Salivary

Anas Eid, MD, Sarah E Langsdon, BS, Courtney B Shires, MD

University of Tennessee


D203

SENSITIVITY OF FINE NEEDLE ASPIRATION AND IMAGING MODALITIES IN THE DIAGNOSIS OF LOW GRADE MUCOEPIDERMOID CARCINOMA OF THE PAROTID GLAND

Salivary

Samuel L Garrett, Kiley Trott, MD, Christopher Sebastiano, MD, Michael J Wolf, MD, Neeta K Rao, MD, Joseph M Curry, MD, David M Cognetti, MD, Adam J Luginbuhl, MD

Thomas Jefferson University


D204

INHIBITION OF WNT/BETA-CATENIN PATHWAY AS A THERAPEUTIC TARGET IN ADENOID CYSTIC CARCINOMA

Salivary

Hyun-su Kim1, Joseph O Humtsoe1, Brandon Leonard1, Bhumsuk Keam2, Luigi Marchionni3, Elana J Fertig3, Patrick Ha1

1Department of Otolaryngology, University of California San Francisco, San Francisco, CA, 2Department of Medical Oncology, Seoul National University, Seoul, Korea, 3Department of Biostatistics and Bioinformatics, Johns Hopkins University, Baltimore, MD


D205

HMG2 AND PLAG1 PROTEIN EXPRESSION IN PLEOMORPHIC ADENOMA TUMORIGENESIS AND IN THE PROGRESSION TO CARCINOMA EX PLEOMORPHIC ADENOMA

Salivary

Louyse V Carvalho1, João F Scarini2, Reydson Alcides L Souza2, Erika S Egal1, Antonio S Martins1, André Casarim1, Agrício N Crespo1, Oslei P Almeida1, Albina Altemani1, Fernanda V Mariano1, Luiz P Kowalski3

1School of Medical Sciences - UNICAMP, 2Piracicaba Dental School - UNICAMP, 3AC Camargo Cancer Center


D206

MANAGEMENT OF LOW RISK SALIVARY GLAND CARCINOMAS WITH SURGERY ALONE

Salivary

Sepehr Shabani, MD1, Abhay Varun Sharma, MD1, Matthew Carmichael, MD1, Matthew Mifsud, MD1, Tapan Padhya, MD2

1University of South Florida-Morsani College of Medicine, 2H. Lee Moffitt Cancer Center & Research Institute


D207

SALIVARY CLEAR CELL CARCINOMA CLINICOPATHOLOGIC CHARACTERISTICS AND OUTCOMES: A POPULATION-BASED ANALYSIS

Salivary

Daniel Sharbel, MD, Aykut Unsal, DO, William G Albergotti, MD, James K Byrd, MD

Augusta University Department of Otolaryngology-Head and Neck Surgery


D208

INTERMEDIATE-GRADE CARCINOMA OF THE PAROTID: A NATIONAL CANCER DATABASE STUDY

Salivary

Lauren M North, MD1, Michael Stadler, MD1, Becky Massey, MD1, Bruce Campbell, MD1, Monica Shukla, MD1, Musaddiq Awan, MD1, Christopher J Schultz, MD1, Stuart Wong, MD1, Evan Graboyes, MD2, Patrick Pipkorn, MD3, Joseph Zenga, MD1

1Medical College of Wisconsin, 2Medical University of South Carolina, 3Washington University School of Medicine


D209

OUTCOMES AND RISK FACTORS OF DISEASE PROGRESSION IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK: THE UW/SCCA EXPERIENCE

Salivary

Hannan Qureshi, MD, Jeffrey J Houlton, MD, Keith D Eaton, MD, PhD, Brittany R Barber, MD, MSc, Neal D Futran, MD, DMD, Cristina P Rodriguez, MD

University of Washington